1036 related articles for article (PubMed ID: 15943939)
21. Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.
Welle-Strand GK; Skurtveit S; Jansson LM; Bakstad B; Bjarkø L; Ravndal E
Acta Paediatr; 2013 Nov; 102(11):1060-6. PubMed ID: 23909865
[TBL] [Abstract][Full Text] [Related]
22. Association between intrapartum fetal heart rate patterns and neonatal abstinence syndrome in methadone exposed neonates.
Leeman LM; Brown SA; Albright B; Skipper B; Hsi A; Rayburn WF
J Matern Fetal Neonatal Med; 2011 Jul; 24(7):955-9. PubMed ID: 21142769
[TBL] [Abstract][Full Text] [Related]
23. Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.
O'Connor AB; Collett A; Alto WA; O'Brien LM
J Midwifery Womens Health; 2013; 58(4):383-8. PubMed ID: 23931660
[TBL] [Abstract][Full Text] [Related]
24. [Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept].
Rohrmeister K; Bernert G; Langer M; Fischer G; Weninger M; Pollak A
Z Geburtshilfe Neonatol; 2001; 205(6):224-30. PubMed ID: 11745008
[TBL] [Abstract][Full Text] [Related]
25. Buprenorphine and naloxone compared with methadone treatment in pregnancy.
Wiegand SL; Stringer EM; Stuebe AM; Jones H; Seashore C; Thorp J
Obstet Gynecol; 2015 Feb; 125(2):363-368. PubMed ID: 25569005
[TBL] [Abstract][Full Text] [Related]
26. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
27. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
28. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].
Loustauneau A; Auriacombe M; Daulouede JP; Tignol J
Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S31-6. PubMed ID: 12518080
[TBL] [Abstract][Full Text] [Related]
29. Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale.
Jones HE; O'Grady KE; Johnson RE; Velez M; Jansson LM
Subst Use Misuse; 2010 Nov; 45(13):2244-57. PubMed ID: 20482340
[TBL] [Abstract][Full Text] [Related]
30. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.
Winklbaur B; Kopf N; Ebner N; Jung E; Thau K; Fischer G
Addiction; 2008 Sep; 103(9):1429-40. PubMed ID: 18783498
[TBL] [Abstract][Full Text] [Related]
31. Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a prospective randomized trial.
Kirchner L; Graf-Rohrmeister K; Klebermass-Schrehof K; Weninger M; Jagsch R; Metz V; Unger A; Fischer G
Klin Padiatr; 2014 Sep; 226(5):274-80. PubMed ID: 25062111
[TBL] [Abstract][Full Text] [Related]
32. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
Brogly SB; Saia KA; Walley AY; Du HM; Sebastiani P
Am J Epidemiol; 2014 Oct; 180(7):673-86. PubMed ID: 25150272
[TBL] [Abstract][Full Text] [Related]
33. Are there gender related differences in neonatal abstinence syndrome following exposure to buprenorphine during pregnancy?
O'Connor AB; O'Brien L; Alto WA
J Perinat Med; 2013 Sep; 41(5):621-3. PubMed ID: 23612625
[TBL] [Abstract][Full Text] [Related]
34. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
35. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Kaltenbach K; Holbrook AM; Coyle MG; Heil SH; Salisbury AL; Stine SM; Martin PR; Jones HE
Addiction; 2012 Nov; 107 Suppl 1(0 1):45-52. PubMed ID: 23106926
[TBL] [Abstract][Full Text] [Related]
36. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
[TBL] [Abstract][Full Text] [Related]
37. Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Metz V; Jagsch R; Ebner N; Würzl J; Pribasnig A; Aschauer C; Fischer G
Hum Psychopharmacol; 2011 Aug; 26(6):412-21. PubMed ID: 21823171
[TBL] [Abstract][Full Text] [Related]
38. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
39. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.
Lejeune C; Simmat-Durand L; Gourarier L; Aubisson S;
Drug Alcohol Depend; 2006 May; 82(3):250-7. PubMed ID: 16257138
[TBL] [Abstract][Full Text] [Related]
40. Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
Noormohammadi A; Forinash A; Yancey A; Crannage E; Campbell K; Shyken J
Ann Pharmacother; 2016 Aug; 50(8):666-72. PubMed ID: 27199497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
